Evidence map›Paper›PMID 34386747›Full record

ArticleEClinicalMedicine2021

Endovascular therapy for superior vena cava syndrome: A systematic review and meta-analysis.

Abdul Hussain Azizi, Irfan Shafi, Matthew Zhao, Saurav Chatterjee, Stephanie Clare Roth, Maninder Singh, Vladimir Lakhter, Riyaz Bashir

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Patient characteristics and the safety of stent placement for malignant vena cava syndrome in Japan: a nationwide analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  4. Article
  5. Contemporary management of superior vena cava syndrome.Journal of vascular surgery. Venous and lymphatic disorders · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Endovascular Treatment for Upper Body Central Venous Obstruction.Interventional radiology (Higashimatsuyama-shi (Japan) · 2025
    Article
  14. Inferior and Superior Vena Cava Reconstruction.Cardiovascular and interventional radiology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article
  19. Catheter-associated superior vena cava syndrome.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Abdul Hussain AziziDepartment of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Irfan ShafiDepartment of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, United States.
Matthew ZhaoDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Saurav ChatterjeeDivision of Cardiology, Department of Medicine, Northshore-LIJ Hospitals of Northwell Health, and Assistant Professor of Medicine, Zucker School of Medicine, New York, NY, United States.
Stephanie Clare RothGinsburg Health Sciences Library, Temple University, Philadelphia, PA, United States.
Maninder SinghDivision of Cardiovascular Disease, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Vladimir LakhterDivision of Cardiovascular Disease, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Riyaz BashirDivision of Cardiovascular Disease, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Temple University · USNorthwell Health · USTemple University Health System · USUniversity of California, Los Angeles · USWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSuperior vena cava (SVC) syndrome is caused by the obstruction of the SVC and can result in significant morbidity and mortality. In contemporary practice, endovascular therapy (ET) has become the standard of care for a majority of these patients. This study is a systematic review and meta-analysis of the available literature to assess technical success, restenosis, and recurrence of SVC syndrome following endovascular intervention.

methodsFor this meta-analysis, we conducted a systematic literature review of PubMed, Cochrane Library, and Embase databases from inception to April 14, 2021 for studies on ET for SVC syndrome. Studies included full-length journal articles on the use of ET among adults with SVC syndrome. Case reports or case series with fewer than 20 patients were excluded. We evaluated the endpoints of technical success rate, restenosis rate, and recurrence rates in SVC syndrome patients after endovascular stenting. The results of this study were calculated using random-effects models.

findingsWe identified 6,012 reports, of which 39 studies met our inclusion criteria and were included for analysis. A total of 2200 patients received ET for SVC syndrome. The weighted technical success rate was 98.8% (95% CI 98.2-99.3) with low heterogeneity (I

interpretationOur systematic review revealed high technical success, low restenosis, and low recurrence rates following ET. Collectively, these results support the paradigm of ET as an effective and safe treatment for patients with SVC syndrome.

fundingNone.

Indexed as

AngioplastyCatheter-directed thrombolysisEndovascular therapyStentsSuperior vena cava syndrome

Identifiers

PMID34386747
PMCPMC8343254
OpenAlexW3173432723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.